Morgan Stanley raises Vir Biotechnology target price to $24
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Gelonghui, February 25th|Morgan Stanley has raised the target price of Vir Biotechnology from $20 to $24, maintaining an "Overweight" rating. (Gelonghui)
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
BUZZ - Nike shares rise, aiming for $5 billion revenue growth by 2031
路透社•2026/11/17 15:36

Solutions 30 Postpones Strategy Webinar
Bitget•2026/11/17 15:29
Crypto prices
MoreBitcoin
BTC
$63,869.19
-1.25%
Ethereum
ETH
$1,779.92
-2.45%
Tether USDt
USDT
$0.9993
+0.03%
BNB
BNB
$586.43
-0.50%
USDC
USDC
$0.9999
+0.02%
XRP
XRP
$0.9610
+0.53%
Solana
SOL
$72.4
+1.91%
TRON
TRX
$0.3075
+0.52%
Hyperliquid
HYPE
$68.04
+2.12%
Zcash
ZEC
$935.46
+5.64%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now